ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
PiggyBac-Engineered Membrane-Bound IL7 TILs Combined with Anti-PD-1 Antibody Demonstrates Efficacy in Recurrent Ovarian Cancer: A First-in-Human Phase I Trial.
Jing Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.